Search images on Google Product Monograph
Active Ingredients:
- cytarabine, 100 MG/ML
DIN: 02515296
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: STERIMAX INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01B - ANTIMETABOLITES (ATC, WHO)
- L01BC - Pyrimidine analogues (ATC, WHO)
- L01BC01 - CYTARABINE (WHO)
Reference brand drug: Cytosar
Pharmaceutical standard: MFR